Total Sales Increased by 2.5% to $13.8 Million, Compared to the Prior Year PeriodNet sales for the first quarter of 2025 were $13.8 million, up 2.5%, compared to $13.5 million for the first quarter of 2024 Building Supply segment sales increased by $132,000 or 1.6%, to $8.4 million, compared to $8.2 million for the three months ended March 31, 2024Disposable Protective Apparel segment sales increased by $208,000 or 4.0%, to $5.5 million, compared to $5.2 million for the same period of 2024 Net income for th ...

GROSSE POINTE FARMS, Mich., May 08, 2025 (GLOBE NEWSWIRE) -- Saga Communications, Inc. (Nasdaq - SGA) (the “Company”, “Saga”, “we” or “our”) today reported that net revenue decreased 4.3% to $24.2 million for the quarter ended March 31, 2025 compared to $25.3 million for the same period last year. Station operating expense decreased 2.2% for the quarter to $22.0 million compared to the same period last year. For the quarter, our operating loss was $2.3 million compared to an operating loss of $2.4 million f ...

Conference Call to be held Wednesday, May 14, 2025 at 4:30 p.m. Eastern TimeSAN JUAN, Puerto Rico, May 08, 2025 (GLOBE NEWSWIRE) -- Red Cat (Nasdaq: RCAT) ("Red Cat" or the "Company"), a drone technology company integrating robotic hardware and software for military, government, and commercial operations, announces that financial results for the Q1 2025 period will be reported on Wednesday, May 14, 2025 at the market close. Company management will host an earnings conference call at 4:30p.m. ET on Wednesday ...

World leader in polar science and polar operations research to use additional drones to enhance its Antarctic conservation, research, and wildlife preservation efforts WICHITA, Kan., May 08, 2025 (GLOBE NEWSWIRE) -- AgEagle Aerial Systems Inc. (NYSE: UAVS), a leading provider of best-in-class unmanned aerial systems (UAS) and sensors for military, public safety, and commercial use, has sold two additional eBee VISION drones to the British Antarctic Survey (BAS), a world leader in polar science and polar op ...

ATHENS, Greece, May 08, 2025 (GLOBE NEWSWIRE) -- Star Bulk Carriers Corp. (the "Company" or "Star Bulk") (Nasdaq: SBLK), today announced that it will release its results for the first quarter ended March 31, 2025, after the market closes in New York on Wednesday, May 14, 2025. Star Bulk's management team will host a conference call to discuss the Company's financial results on Thursday, May 15, 2025, at 11:00 a.m. Eastern Time (ET). Conference Call details: Participants should dial into the call 10 minutes ...

OCALA, Fla., May 08, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (OTC Pink: AIMI) (“AIM” or the “Company”) today announced the presentation of clinical trial data involving AIM’s drug Ampligen by Pawel Kalinski, MD, PhD, at the recent Annual Meeting of the American Association of Immunologists held May 3-7, 2025, in Honolulu, HI. The paper, titled “Systemic Infusion of dsRNA (Rintatolimod) plus IFN Promotes Selective Influx of CTLs (but not Treg) into the TME — Counteracting Chemokine ...

BOCA RATON, Fla., May 08, 2025 (GLOBE NEWSWIRE) -- Springbig (OTCQB: SBIG), a leading provider of marketing automation software and customer loyalty solutions, is excited to announce the addition of three seasoned executives to its leadership team. These strategic hires reflect the company’s commitment to continued growth, innovation, and operational excellence as it scales its SaaS platform and services across North America. Springbig also recently announced that Jaret Christopher has joined the company as ...

The Independent Data Monitoring Committee (IDMC) has recommended to continue the study as planned as there are no safety concerns seen in the data reviewed Continued momentum with completed patient enrollment for the 6-week interim analysis (N=24) and over two-thirds enrollment completed for the overall trial Results on track for interim data in Q2 2025 and topline data in Q3 2025 Management releases “What This Means” segment discussing the interim biomarker data; Access Here LA JOLLA, CA, May 08, 2025 (GLO ...

Please see enclosed pdf. Attachment 08052025_trading_in_shares_GL ...

Video illustrates SENTI-202’s MoA, namely to selectively kill both AML blasts and leukemic stem cells (LSCs) while protecting healthy hematopoietic stem cells/ hematopoietic stem and progenitor cells (HSC/HSPCs) using its novel CD33 OR FLT3 NOT EMCN Logic-Gated gene circuitAccess video here SOUTH SAN FRANCISCO, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio” or the “Company”), a clinical-stage biotechnology company developing next-generation cell and gene therapi ...